BRATTON DOUGLAS K [Rocket]

Date Filed	Type	Description
05/03/2023	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2023	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/21/2022	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/13/2022	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/18/2022	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2022	SC 13G/A	BRATTON DOUGLAS K reports a 6.4% stake in DENALI THERAPEUTICS INC.
02/11/2022	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021	SC 13G/A	BRATTON DOUGLAS K reports a 10.3% stake in DENALI THERAPEUTICS INC.
02/09/2021	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/04/2020	SC 13D	BRATTON DOUGLAS K reports a 16.3% stake in Midwest Holding Inc.
02/12/2020	SC 13G/A	BRATTON DOUGLAS K reports a 46.3% stake in Aquestive Therapeutics, Inc.
02/11/2020	SC 13G/A	BRATTON DOUGLAS K reports a 21.3% stake in DENALI THERAPEUTICS INC.
02/13/2019	SC 13G	BRATTON DOUGLAS K reports a 46.4% stake in Aquestive Therapeutics, Inc.
02/13/2018	SC 13G	BRATTON DOUGLAS K reports a 22.8% stake in DENALI THERAPEUTICS INC.
02/07/2018	SC 13D/A	BRATTON DOUGLAS K reports a 4.7% stake in Juno Therapeutics, Inc.
11/08/2017	SC 13D/A	BRATTON DOUGLAS K reports a 6.7% stake in Juno Therapeutics, Inc.
07/17/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]